Rare diseases
Investigational molecules
Locations
Back to Croatia11 clinical trials in Slavonski Brod, Croatia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
CroatiaStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
CroatiaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
CroatiaStudy on the Safety and Effectiveness of Contezolid Acefosamil, Contezolid, and Linezolid for Adults with Moderate or Severe Diabetic Foot Infections
CroatiaStudy Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis
CroatiaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
CroatiaStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
CroatiaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
CroatiaA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
CroatiaTitle: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis
CroatiaStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
CroatiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on atherosclerotic cardiovascular disease (ASCVD) prevention and treatment. Studies evaluate new therapeutic approaches for reducing major cardiovascular events.
Multiple trials are investigating novel compounds for improving cardiovascular outcomes in high-risk patients.
Research examining advanced treatments for Diffuse Large B-Cell Lymphoma (DLBCL), evaluating combination therapies with standard treatment protocols to enhance patient outcomes.
Cutting-edge investigations into improving survival rates for newly diagnosed lymphoma patients.
Studies focusing on moderate to severe ulcerative colitis treatment options, comparing novel biosimilars with established medications to provide more effective therapeutic alternatives.
Innovative research aimed at improving quality of life for patients with inflammatory bowel conditions.
Clinical research addressing diabetic foot infections, evaluating new antimicrobial treatments compared to standard therapies for improved patient outcomes.
Comprehensive assessment of novel therapeutic options for managing diabetic complications.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
